Allogeneic hematopoietic stem cell transplantation in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy35

Hematopoietic Stem Cells Stem Cells Allografts T-Lymphocytes Antilymphocyte Serum Bone Marrow Cells Fetal Blood Embryonic Stem Cells Adult Stem Cells Bone Marrow Thymus Gland Cells, Cultured CD8-Positive T-Lymphocytes Killer Cells, Natural Mesenchymal Stromal Cells CD4-Positive T-Lymphocytes T-Lymphocytes, Regulatory B-Lymphocytes Pluripotent Stem Cells Multipotent Stem Cells Fetal Stem Cells Neural Stem Cells Hematopoietic System Induced Pluripotent Stem Cells Blood Cells Mesonephros T-Lymphocytes, Cytotoxic Dendritic Cells Spleen T-Lymphocyte Subsets Myeloid Progenitor Cells Neoplastic Stem Cells Lymphocytes Stromal Cells Liver

Organisms13

Transplantation Chimera Cytomegalovirus Mice, Inbred C57BL Mice, Inbred BALB C Mice, SCID BK Virus Mice, Inbred NOD Radiation Chimera Mice, Transgenic Mice, Knockout Lentivirus Retroviridae Chimera

Diseases54

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia Hematologic Diseases Myelodysplastic Syndromes Leukemia, Myeloid, Acute Hepatic Veno-Occlusive Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Cytomegalovirus Infections Acute Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemic Infiltration Cystitis Anemia, Aplastic Opportunistic Infections Multiple Myeloma Severe Combined Immunodeficiency Neoplasm, Residual Lymphoproliferative Disorders Bronchiolitis Obliterans Blood Group Incompatibility Mycoses Leukemia, Myeloid Primary Myelofibrosis Chronic Disease Epstein-Barr Virus Infections Leukemia-Lymphoma, Adult T-Cell Aspergillosis Neoplasms Lymphoma, Non-Hodgkin Disease Progression Infection Neoplasm Recurrence, Local Neoplasms, Second Primary Hodgkin Disease Stomatitis Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma Postoperative Complications Immunologic Deficiency Syndromes Roseolovirus Infections Sarcoma, Myeloid Pancytopenia Fanconi Anemia Lymphohistiocytosis, Hemophagocytic Disease Models, Animal Neutropenia Bacteremia Mucopolysaccharidosis I Thrombotic Microangiopathies beta-Thalassemia Bone Marrow Diseases Adenoviridae Infections

Chemicals and Drugs39

Myeloablative Agonists Busulfan Vidarabine HLA Antigens Immunosuppressive Agents Minor Histocompatibility Antigens Antigens, CD34 Antilymphocyte Serum Cyclophosphamide Ganciclovir Isoantigens Cytarabine Cyclosporine Melphalan Antibodies, Neoplasm Antineoplastic Agents HLA-A Antigens Granulocyte Colony-Stimulating Factor Pyrimidines Antifungal Agents Antibodies, Monoclonal Biological Markers Antiviral Agents Stem Cell Factor Antigens, CD Antineoplastic Agents, Alkylating Thiotepa Etoposide Cytokines Triazoles Proto-Oncogene Proteins c-kit Tacrolimus Vincristine DNA, Viral Receptors, KIR Carmustine ABO Blood-Group System Amphotericin B Antigens, Viral

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Stem Cell Transplantation Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Treatment Outcome Bone Marrow Transplantation Whole-Body Irradiation Retrospective Studies Histocompatibility Testing Cord Blood Stem Cell Transplantation Lymphocyte Transfusion Remission Induction Survival Rate Survival Analysis Combined Modality Therapy Disease-Free Survival Transplantation, Isogeneic Lymphocyte Depletion Hematopoietic Stem Cell Mobilization Flow Cytometry Follow-Up Studies Salvage Therapy Liver Transplantation Risk Factors Photopheresis Prognosis Immunosuppression Fatal Outcome Antineoplastic Combined Chemotherapy Protocols Mesenchymal Stem Cell Transplantation Cell Transplantation Incidence Prospective Studies Kidney Transplantation Multivariate Analysis Colony-Forming Units Assay Lymphocyte Count Donor Selection Immunotherapy Cell Separation Cohort Studies Immunophenotyping Kaplan-Meier Estimate Polymerase Chain Reaction Clinical Trials as Topic Heart Transplantation Transplantation Organ Transplantation Immunotherapy, Adoptive Lymphocyte Activation Lung Transplantation Cell Culture Techniques Risk Chemoprevention Platelet Transfusion Severity of Illness Index Leukapheresis Blood Cell Count Islets of Langerhans Transplantation Transplantation, Heterologous Case-Control Studies Cell Count Transduction, Genetic Genetic Therapy Reverse Transcriptase Polymerase Chain Reaction Leukocyte Transfusion Fetal Tissue Transplantation Disease Models, Animal Viral Load Feasibility Studies Bone Marrow Purging Coculture Techniques Pancreas Transplantation Leukocyte Count Cell- and Tissue-Based Therapy Blood Grouping and Crossmatching

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes33

Graft vs Leukemia Effect Graft vs Tumor Effect Histocompatibility Chimerism Graft Survival Transplantation Immunology Time Factors Hematopoiesis Immunocompromised Host Cell Differentiation Cell Lineage Stem Cell Niche Graft Rejection Virus Activation Lymphocyte Count Cell Proliferation Lymphocyte Activation Transplantation Tolerance Lymphopoiesis Risk Radiation Chimera Regeneration Blood Cell Count Cell Count Genotype Transduction, Genetic Phenotype Recovery of Function Viral Load Genetic Vectors Cell Survival Leukocyte Count Cell Division

Disciplines and Occupations1

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups7

Tissue Donors Siblings Survivors Unrelated Donors Living Donors Infant, Newborn Blood Donors

Health Care19

Treatment Outcome Retrospective Studies Survival Rate Survival Analysis Disease-Free Survival Follow-Up Studies Risk Factors Fatal Outcome Incidence Prospective Studies Multivariate Analysis Donor Selection Cohort Studies Kaplan-Meier Estimate Clinical Trials as Topic Risk Severity of Illness Index Case-Control Studies Feasibility Studies

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Graft vs Host Disease Transplantation Conditioning Hematopoietic Stem Cells Hematologic Neoplasms Stem Cell Transplantation Transplantation, Autologous Graft vs Leukemia Effect Peripheral Blood Stem Cell Transplantation Transplantation Chimera Tissue Donors Myeloablative Agonists Treatment Outcome Bone Marrow Transplantation Busulfan Graft vs Tumor Effect Histocompatibility Chimerism Recurrence Whole-Body Irradiation Retrospective Studies Leukemia Histocompatibility Testing Stem Cells Allografts Vidarabine Graft Survival Hematologic Diseases Cord Blood Stem Cell Transplantation Myelodysplastic Syndromes Leukemia, Myeloid, Acute Siblings Lymphocyte Transfusion HLA Antigens Immunosuppressive Agents Remission Induction Hepatic Veno-Occlusive Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Survival Rate Cytomegalovirus Infections Survival Analysis Transplantation Immunology Acute Disease Time Factors Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemic Infiltration Combined Modality Therapy Disease-Free Survival Cystitis Anemia, Aplastic Transplantation, Isogeneic T-Lymphocytes Minor Histocompatibility Antigens Hematopoiesis Opportunistic Infections Lymphocyte Depletion Hematopoietic Stem Cell Mobilization Multiple Myeloma Severe Combined Immunodeficiency Neoplasm, Residual Flow Cytometry Follow-Up Studies Salvage Therapy Lymphoproliferative Disorders Antigens, CD34 Antilymphocyte Serum Cyclophosphamide Cytomegalovirus Bronchiolitis Obliterans Bone Marrow Cells Liver Transplantation Risk Factors Mice, Inbred C57BL Immunocompromised Host Blood Group Incompatibility Photopheresis Mycoses Cell Differentiation Prognosis Immunosuppression Fatal Outcome Leukemia, Myeloid Antineoplastic Combined Chemotherapy Protocols Survivors Primary Myelofibrosis Mesenchymal Stem Cell Transplantation Ganciclovir Fetal Blood Cell Transplantation Unrelated Donors Cell Lineage Isoantigens Chronic Disease Cytarabine Incidence Stem Cell Niche Graft Rejection Embryonic Stem Cells Cyclosporine

No FAQ available that match "allogeneic hematopoietic stem cell transplantation in patients"